Skip to main content
Erschienen in: Pediatric Nephrology 3/2018

02.10.2017 | Original Article

Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease

verfasst von: Nattaphorn Hongsawong, Prapimdaw Khamdee, Suchaya Silvilairat, Wattana Chartapisak

Erschienen in: Pediatric Nephrology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Cyanotic nephropathy (CN), seen in 30–50% of patients with congenital cyanotic heart disease (CCHD), affects both tubular and glomerular function, resulting in proteinuria and azotemia. Microalbuminuria is an early marker for glomerular damage and an independent predictor of progressive renal disease.

Methods

A cross-sectional study was conducted. A total of 116 patients aged 1 month to 15 years with CCHD at Chiang Mai University Hospital between 2015 and 2016 were assessed and 94 patients were enrolled. To determine the prevalence and associated factors of significant albuminuria in CCHD patients, baseline characteristics, oxygen saturation, surgery, hemoglobin (Hb), hematocrit (Hct), spot urine albumin, urine protein, and creatinine were obtained. Binary logistic-regression modeling was used to identify associated factors.

Results

Prevalence of CN in children with CCHD was 58.51% and 92.55% according to albuminuria and proteinuria staging respectively. Prevalence of significant proteinuria, significant albuminuria, and decreased GFR was 88.30%, 41.49% and 31.91% respectively. Participants with significant albuminuria had fewer previous surgeries (p = 0.05), a longer waiting time for surgery (p = 0.02), enalapril usage (p = 0.04), pulmonary hypertension (p = 0.03), higher Hct z-score (p = 0.03) and lower platelet count (p = 0.001) compared with those without significant albuminuria. Using multivariate logistic regression analysis, waiting duration for surgery (p = 0.04), Hct >40% (p = 0.02), and platelet count <290,000/mm3 (p = 0.04) were predictive of microalbuminuria.

Conclusions

Cyanotic nephropathy can be detected in the first decade of life with the presentation of microalbuminuria. High Hct level and low platelet count were identified as a predictor of microalbuminuria, whereas early cardiac surgery decreased the risk of developing significant albuminuria.
Literatur
1.
Zurück zum Zitat Meessen H, Litton MA (1953) Morphology of the kidney in morbus caeruleus. AMA Arch Pathol 56:480–487PubMed Meessen H, Litton MA (1953) Morphology of the kidney in morbus caeruleus. AMA Arch Pathol 56:480–487PubMed
2.
Zurück zum Zitat Dittrich S, Kurschat K, Lange PE (2001) Abnormal rheology in cyanotic congenital heart disease—a factor in non-immune nephropathy. Scand J Urol Nephrol 35:411–415CrossRefPubMed Dittrich S, Kurschat K, Lange PE (2001) Abnormal rheology in cyanotic congenital heart disease—a factor in non-immune nephropathy. Scand J Urol Nephrol 35:411–415CrossRefPubMed
3.
Zurück zum Zitat Agras PI, Derbent M, Ozcay F, Baskin E, Turkoglu S, Aldemir D, Tokel K, Saatci U (2005) Effect of congenital heart disease on renal function in childhood. Nephron Physiol 99:10–15CrossRef Agras PI, Derbent M, Ozcay F, Baskin E, Turkoglu S, Aldemir D, Tokel K, Saatci U (2005) Effect of congenital heart disease on renal function in childhood. Nephron Physiol 99:10–15CrossRef
4.
Zurück zum Zitat Zheng J, Yao Y, Han L, Xiao Y (2013) Renal function and injury in infants and young children with congenital heart disease. Pediatr Nephrol 28:99–104CrossRefPubMed Zheng J, Yao Y, Han L, Xiao Y (2013) Renal function and injury in infants and young children with congenital heart disease. Pediatr Nephrol 28:99–104CrossRefPubMed
5.
Zurück zum Zitat Akita H, Matsuoka S, Kuroda Y (1993) Nephropathy in patients with cyanotic congenital heart disease. Tokushima J Exp Med 40:47–53PubMed Akita H, Matsuoka S, Kuroda Y (1993) Nephropathy in patients with cyanotic congenital heart disease. Tokushima J Exp Med 40:47–53PubMed
6.
Zurück zum Zitat Inatomi J, Matsuoka K, Fujimaru R, Nakagawa A, Iijima K (2006) Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol 21:1440–1445CrossRefPubMed Inatomi J, Matsuoka K, Fujimaru R, Nakagawa A, Iijima K (2006) Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol 21:1440–1445CrossRefPubMed
7.
Zurück zum Zitat Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157:1413–1418CrossRefPubMed Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157:1413–1418CrossRefPubMed
8.
Zurück zum Zitat Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139:901–906CrossRefPubMed Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139:901–906CrossRefPubMed
10.
Zurück zum Zitat Flanagan MF, Hourihan M, Keane JF (1991) Incidence of renal dysfunction in adults with cyanotic congenital heart disease. Am J Cardiol 68:403–406CrossRefPubMed Flanagan MF, Hourihan M, Keane JF (1991) Incidence of renal dysfunction in adults with cyanotic congenital heart disease. Am J Cardiol 68:403–406CrossRefPubMed
11.
Zurück zum Zitat Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC Jr, Ichikawa I (1990) Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38:115–123CrossRefPubMed Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC Jr, Ichikawa I (1990) Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38:115–123CrossRefPubMed
12.
Zurück zum Zitat Spear GS (1960) Glomerular alterations in cyanotic congenital heart disease. Bull Johns Hopkins Hosp 106:347–367PubMed Spear GS (1960) Glomerular alterations in cyanotic congenital heart disease. Bull Johns Hopkins Hosp 106:347–367PubMed
13.
Zurück zum Zitat Spear GS, Kihara I (1964) The glomerulus in cyanotic congenital heart disease: an immunofluorescent study. Bull Johns Hopkins Hosp 115:481–493PubMed Spear GS, Kihara I (1964) The glomerulus in cyanotic congenital heart disease: an immunofluorescent study. Bull Johns Hopkins Hosp 115:481–493PubMed
14.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150CrossRef
15.
Zurück zum Zitat Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Flegal KM, Cole TJ (2013) Construction of LMS parameters for the Centers for Disease Control and Prevention 2000 growth charts. Natl Health Stat Report (63):1–3 Flegal KM, Cole TJ (2013) Construction of LMS parameters for the Centers for Disease Control and Prevention 2000 growth charts. Natl Health Stat Report (63):1–3
17.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576CrossRef
18.
Zurück zum Zitat Dallman P (1977) Blood and blood-forming tissue. In: Rudolph A (ed) Pediatrics. Appleton-Century-Crofts, Norwalk, CT Dallman P (1977) Blood and blood-forming tissue. In: Rudolph A (ed) Pediatrics. Appleton-Century-Crofts, Norwalk, CT
19.
Zurück zum Zitat Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119CrossRefPubMed Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119CrossRefPubMed
20.
Zurück zum Zitat Krull F, Ehrich JH, Wurster U, Toel U, Rothganger S, Luhmer I (1991) Renal involvement in patients with congenital cyanotic heart disease. Acta Paediatr Scand 80:1214–1219CrossRefPubMed Krull F, Ehrich JH, Wurster U, Toel U, Rothganger S, Luhmer I (1991) Renal involvement in patients with congenital cyanotic heart disease. Acta Paediatr Scand 80:1214–1219CrossRefPubMed
21.
Zurück zum Zitat Birn H, Christensen EI (2006) Renal albumin absorption in physiology and pathology. Kidney Int 69:440–449CrossRefPubMed Birn H, Christensen EI (2006) Renal albumin absorption in physiology and pathology. Kidney Int 69:440–449CrossRefPubMed
22.
Zurück zum Zitat Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA (2008) Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 117:2320–2328CrossRefPubMed Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA (2008) Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 117:2320–2328CrossRefPubMed
23.
Zurück zum Zitat Eckardt KU, Hartmann W, Vetter U, Pohlandt F, Burghardt R, Kurtz A (1990) Serum immunoreactive erythropoietin of children in health and disease. Eur J Pediatr 149:459–464CrossRefPubMed Eckardt KU, Hartmann W, Vetter U, Pohlandt F, Burghardt R, Kurtz A (1990) Serum immunoreactive erythropoietin of children in health and disease. Eur J Pediatr 149:459–464CrossRefPubMed
24.
Zurück zum Zitat Scott HW Jr, Elliott SR 2nd (1950) Renal hemodynamics in congenital cyanotic heart disease. Bull Johns Hopkins Hosp 86:58–71PubMed Scott HW Jr, Elliott SR 2nd (1950) Renal hemodynamics in congenital cyanotic heart disease. Bull Johns Hopkins Hosp 86:58–71PubMed
25.
Zurück zum Zitat Malizia E (1956) Renal function and hemodynamics in primary and secondary polycythemia. Acta Med Scand 154:399–406CrossRefPubMed Malizia E (1956) Renal function and hemodynamics in primary and secondary polycythemia. Acta Med Scand 154:399–406CrossRefPubMed
26.
Zurück zum Zitat Becker EL, Schilling JA, Harvey RB (1957) Renal function in man acclimatized to high altitude. J Appl Physiol 10:79–80CrossRefPubMed Becker EL, Schilling JA, Harvey RB (1957) Renal function in man acclimatized to high altitude. J Appl Physiol 10:79–80CrossRefPubMed
27.
Zurück zum Zitat Dent GA, Herman JH, Siegel JE (2007) Laboratory hematology. In: Kahn MJ, Gregory SA (eds) American Society of Hematology self-assessment program. The American Society of Hematology, Washington, DC, pp 444–465 Dent GA, Herman JH, Siegel JE (2007) Laboratory hematology. In: Kahn MJ, Gregory SA (eds) American Society of Hematology self-assessment program. The American Society of Hematology, Washington, DC, pp 444–465
28.
Zurück zum Zitat Takahashi S, Ooya K, Wada N, Inagaki T, Takana Y, Saito A, Nagata M, Harada K (2003) Partial exchange transfusion improved renal function and proteinuria in a patient with cyanotic heart disease nephropathy. Clin Nephrol 60:222–223CrossRefPubMed Takahashi S, Ooya K, Wada N, Inagaki T, Takana Y, Saito A, Nagata M, Harada K (2003) Partial exchange transfusion improved renal function and proteinuria in a patient with cyanotic heart disease nephropathy. Clin Nephrol 60:222–223CrossRefPubMed
30.
Zurück zum Zitat Linderkamp O, Klose HJ, Betke K, Brodherr-Heberlein S, Buhlmeyer K, Kelson S, Sengespeik C (1979) Increased blood viscosity in patients with cyanotic congenital heart disease and iron deficiency. J Pediatr 95:567–569CrossRefPubMed Linderkamp O, Klose HJ, Betke K, Brodherr-Heberlein S, Buhlmeyer K, Kelson S, Sengespeik C (1979) Increased blood viscosity in patients with cyanotic congenital heart disease and iron deficiency. J Pediatr 95:567–569CrossRefPubMed
31.
Zurück zum Zitat Broberg CS, Bax BE, Okonko DO, Rampling MW, Bayne S, Harries C, Davidson SJ, Uebing A, Khan AA, Thein S, Gibbs JS, Burman J, Gatzoulis MA (2006) Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol 48:356–365CrossRefPubMed Broberg CS, Bax BE, Okonko DO, Rampling MW, Bayne S, Harries C, Davidson SJ, Uebing A, Khan AA, Thein S, Gibbs JS, Burman J, Gatzoulis MA (2006) Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol 48:356–365CrossRefPubMed
32.
Zurück zum Zitat Lill MC, Perloff JK, Child JS (2006) Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol 98:254–258CrossRefPubMed Lill MC, Perloff JK, Child JS (2006) Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol 98:254–258CrossRefPubMed
33.
Zurück zum Zitat Awad H, el-Safty I, Abdel-Gawad M, el-Said S (2003) Glomerular and tubular dysfunction in children with congenital cyanotic heart disease: effect of palliative surgery. Am J Med Sci 325:110–114CrossRefPubMed Awad H, el-Safty I, Abdel-Gawad M, el-Said S (2003) Glomerular and tubular dysfunction in children with congenital cyanotic heart disease: effect of palliative surgery. Am J Med Sci 325:110–114CrossRefPubMed
34.
Zurück zum Zitat Passwell J, Orda S, Modan M, Shem-Tov A, Aladjem A, Boichis H (1976) Abnormal renal functions in cyanotic congenital heart disease. Arch Dis Child 51:803–805CrossRefPubMedPubMedCentral Passwell J, Orda S, Modan M, Shem-Tov A, Aladjem A, Boichis H (1976) Abnormal renal functions in cyanotic congenital heart disease. Arch Dis Child 51:803–805CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Fine LG, Orphanides C, Norman JT (1998) Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 65:S74–S78PubMed Fine LG, Orphanides C, Norman JT (1998) Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 65:S74–S78PubMed
37.
Zurück zum Zitat Spear GS (1964) The glomerulus in cyanotic congenital heart disease and primary pulmonary hypertension. A review. Nephron 1:238–248CrossRefPubMed Spear GS (1964) The glomerulus in cyanotic congenital heart disease and primary pulmonary hypertension. A review. Nephron 1:238–248CrossRefPubMed
38.
Zurück zum Zitat Hida K, Wada J, Yamasaki H, Nagake Y, Zhang H, Sugiyama H, Shikata K, Makino H (2002) Cyanotic congenital heart disease associated with glomerulomegaly and focal segmental glomerulosclerosis: remission of nephrotic syndrome with angiotensin converting enzyme inhibitor. Nephrol Dial Transplant 17:144–147CrossRefPubMed Hida K, Wada J, Yamasaki H, Nagake Y, Zhang H, Sugiyama H, Shikata K, Makino H (2002) Cyanotic congenital heart disease associated with glomerulomegaly and focal segmental glomerulosclerosis: remission of nephrotic syndrome with angiotensin converting enzyme inhibitor. Nephrol Dial Transplant 17:144–147CrossRefPubMed
39.
Zurück zum Zitat Fujimoto Y, Matsushima M, Tsuzuki K, Okada M, Shibata M, Yanase Y, Usui K, Nagashima M (2002) Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor. Clin Nephrol 58:95–102CrossRefPubMed Fujimoto Y, Matsushima M, Tsuzuki K, Okada M, Shibata M, Yanase Y, Usui K, Nagashima M (2002) Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor. Clin Nephrol 58:95–102CrossRefPubMed
40.
Zurück zum Zitat Filler G, Lipshultz SE (2012) Why multidisciplinary clinics should be the standard for treating chronic kidney disease. Pediatr Nephrol 27:1831–1834CrossRefPubMed Filler G, Lipshultz SE (2012) Why multidisciplinary clinics should be the standard for treating chronic kidney disease. Pediatr Nephrol 27:1831–1834CrossRefPubMed
Metadaten
Titel
Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease
verfasst von
Nattaphorn Hongsawong
Prapimdaw Khamdee
Suchaya Silvilairat
Wattana Chartapisak
Publikationsdatum
02.10.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 3/2018
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-017-3804-3

Weitere Artikel der Ausgabe 3/2018

Pediatric Nephrology 3/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.